Pathobiochemistry and clinical use of procalcitonin
- PMID: 12135804
- DOI: 10.1016/s0009-8981(02)00101-8
Pathobiochemistry and clinical use of procalcitonin
Abstract
Induction of the protein procalcitonin during infection and inflammation was first described approximately 10 years ago. A large number of publications, primarily clinical studies, demonstrate the increasing use of procalcitonin in modern clinical practice. However, data on the biological function and origin of procalcitonin is scarce. Findings regarding the possible role and source of procalcitonin in sepsis and infection were recently published, and the pathophysiology of the protein has meanwhile been investigated in various experimental models. Procalcitonin obviously has certain biological functions, and it is also known to be specifically induced. Given the hormonal origin of the mature protein and the inflammation-related functions of its propeptides, some investigators suggest that procalcitonin should be referred to as a "hormokine," although its biological functions should be studied in more detail. This review will survey the data now available in recent publications on the induction, production sources, possible biological functions and clinical uses of procalcitonin.
Comment in
-
Pathobiochemistry and clinical use of procalcitonin.Clin Chim Acta. 2003 Feb;328(1-2):199; author reply 201. doi: 10.1016/s0009-8981(02)00386-8. Clin Chim Acta. 2003. PMID: 12559620 No abstract available.
Similar articles
-
Molecular aspects and natural source of procalcitonin.Clin Chem Lab Med. 1999 Aug;37(8):789-97. doi: 10.1515/CCLM.1999.119. Clin Chem Lab Med. 1999. PMID: 10536927 Review.
-
Pathobiochemistry and clinical use of procalcitonin.Clin Chim Acta. 2003 Feb;328(1-2):199; author reply 201. doi: 10.1016/s0009-8981(02)00386-8. Clin Chim Acta. 2003. PMID: 12559620 No abstract available.
-
Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors.J Clin Endocrinol Metab. 2004 Apr;89(4):1512-25. doi: 10.1210/jc.2002-021444. J Clin Endocrinol Metab. 2004. PMID: 15070906 Review. No abstract available.
-
Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes.Crit Care Med. 2004 Aug;32(8):1715-21. doi: 10.1097/01.ccm.0000134404.63292.71. Crit Care Med. 2004. PMID: 15286549
-
Procalcitonin as an acute phase marker.Ann Clin Biochem. 2001 Sep;38(Pt 5):483-93. doi: 10.1177/000456320103800505. Ann Clin Biochem. 2001. PMID: 11587126 Review.
Cited by
-
Procalcitonin and intestinal ischemia: a review of the literature.World J Gastroenterol. 2014 Dec 21;20(47):17773-8. doi: 10.3748/wjg.v20.i47.17773. World J Gastroenterol. 2014. PMID: 25548475 Free PMC article. Review.
-
Combination of S100B and procalcitonin improves prognostic performance compared to either alone in patients with cardiac arrest: A prospective observational study.Medicine (Baltimore). 2019 Feb;98(6):e14496. doi: 10.1097/MD.0000000000014496. Medicine (Baltimore). 2019. PMID: 30732223 Free PMC article.
-
Procalcitonin-guided antibiotics in severe sepsis.Crit Care. 2008;12(6):309. doi: 10.1186/cc7124. Epub 2008 Dec 4. Crit Care. 2008. PMID: 19090974 Free PMC article. No abstract available.
-
Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia.Crit Care. 2018 May 13;22(1):128. doi: 10.1186/s13054-018-2050-9. Crit Care. 2018. PMID: 29753321 Free PMC article. Clinical Trial.
-
Procalcitonin levels among patients with fever secondary to severe intracerebral infection. A cross-sectional study.Sao Paulo Med J. 2019 Oct 31;137(4):349-355. doi: 10.1590/1516-3180.2018.0458220719. eCollection 2019. Sao Paulo Med J. 2019. PMID: 31691767 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources